Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- COPD Exacerbations Increase Risk of Cardiovascular Events
- Effects of Semaglutide on Chronic Kidney Disease in Patients With Type 2 Diabetes
- Association of Virtual Scribe Use With Physician Time Spent on Electronic Health Records
- Long-Term Effect of Home Blood Pressure Self-Monitoring Plus Medication Self-Titration in Patients With Hypertension
- Association Between Life's Essential 8 Cardiovascular Health Metrics With Cardiovascular Events
- Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity
- Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban
- Concomitant Use of Selective Serotonin Reuptake Inhibitors With OACs and Risk of Major Bleeding
- Development of a Target Concentration Intervention to Individualize Paroxysmal Nocturnal Hemoglobinuria Treatment With Pegcetacoplan
- Real-World Experience of Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria